Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial
Background: Tailoring interventions to patient subgroups can improve intervention outcomes for various conditions. However, it is unclear how much of this improvement is due to the pharmacological personalisation versus the non-specific effects of the contextual factors involved in the tailoring pro...
Main Authors: | Dasha A Sandra, Jay A Olson, Ellen J Langer, Mathieu Roy |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/84691 |
Similar Items
-
Context matters: the psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy
by: Giacomo Rossettini, et al.
Published: (2020-06-01) -
Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviews
by: E Plans-Beriso, et al.
Published: (2024-06-01) -
Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping reviewResearch in context
by: Manasvi Singh, et al.
Published: (2024-07-01) -
The hardest thing to see is what is in front of your eyes – quo vadis placebo analgesia?
by: Conrad R
Published: (2016-10-01) -
Placebo Effects of Open-label Verbal Suggestions on Itch
by: Stefanie H. Meeuwis, et al.
Published: (2017-11-01)